证券代码：688322 证券简称：奥比中光 公告编号：2023-054 奥比中光科技集团股份有限公司 关于续聘2023年度会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 奥比中光科技集团股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日 召开第一届董事会第三十次会议审议通过了《关于续聘 2023 年度会计师事务所 的议案》，拟续聘天健会计师事务所（特殊普通合伙）为公司 2023 年度财务报 表审计机构和内部控制审计机构，公司独立董事对本议案发表了事前认可意见和 同意的独立意见。上述议案尚需提交至公司 2023 年第四次临时股东大会审议， 聘期自公司股东大会审议通过之日起一年。现将具体事项公告如下： 截至 2022 年 12 月 31 日，天健会计师事务所（特殊普通合伙）累计已计提 职业风险基金 1 亿元以上，购买的职业保险累计赔偿限额超过 1 亿元，职业风险 基金计提及职业保险购买符合财政部关于《会计师事务所职业风险基金管理办法》 等文件的相关规定。 近三年天健会计师事务 ...

证券代码：688322 证券简称：奥比中光 公告编号：2023-053 奥比中光科技集团股份有限公司 一、注册地址变更情况 | 变更前 | | | 变更后 | | | --- | --- | --- | --- | --- | | 深圳市南山区粤海街道学府路 63 | 号高新区 深圳市南山区西丽街道松坪山社区高新北 | | | | | 联合总部大厦 12 层 | | 一道 88 | 号奥比科技大厦 | 2001 | 二、《公司章程》修订情况 | 修订前 | | | 修订后 | | --- | --- | --- | --- | | 第五条 | | 公司住所：深圳市南山区粤海街 | 第五条 公司住所：深圳市南山区西丽街道 | | 道学府路 | 63 | 号高新区联合总部大厦 12 | 松坪山社区高新北一道 88 号奥比科技大厦 | | 楼。邮政编码 | | 518052。 | 2001。邮政编码 518000。 | 除上述条款外，《公司章程》中的其他条款内容保持不变，上述变更最终以市场监 督管理局核准的内容为准。具体内容详见公司在上海证券交易所网站（www.sse.com.cn） 披露的《公司章程》全文。 本次 ...

奥比中光科技集团股份有限公司独立董事 关于第一届董事会第三十次会议相关事项的事前认可意见 根据《中华人民共和国公司法》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》（以下简称 "《自律监管指引第 1 号》"）、《上市公司独立董事规则》等法律法规、规范性文 件及《奥比中光科技集团股份有限公司章程》（以下简称"《公司章程》"）、《奥比 中光科技集团股份有限公司独立董事制度》等相关规定，我们作为奥比中光科技 集团股份有限公司（以下简称"公司"）的独立董事，基于独立判断立场，对公 司第一届董事会第三十次会议拟审议的相关事项发表事前认可意见如下： 一、 关于续聘 2023 年度会计师事务所的事前认可意见 经审阅，我们认为：天健会计师事务所（特殊普通合伙）具备为上市公司提 供审计服务的资质和胜任能力，诚信状况良好，在其担任公司财务报表审计机构 期间能够保持工作独立性，勤勉尽责，较好地完成了各项审计工作，为公司出具 的审计报告客观、公正地反映了公司的财务状况和经营成果。本次公司拟续聘天 健会计师事务所（特殊普通合伙）作为 2023 年度财务报表审计机构和内部控制 审 ...

证券代码：688322 证券简称：奥比中光 公告编号：2023-058 奥比中光科技集团股份有限公司 关于变更保荐机构后重新签订募集资金监管协议及 注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 奥比中光科技集团股份有限公司（以下简称"公司"）于 2023 年 7 月 29 日在指 定信息披露媒体《上海证券报》《中国证券报》《证券时报》《证券日报》、经济参考网 （www.jjckb.cn）和上海证券交易所网站（www.sse.com.cn）披露《关于变更保荐机 构的公告》（公告编号：2023-047）。根据公司 2023 年度向特定对象发行 A 股股票（以 下简称"本次发行"）需要并经股东大会授权，公司聘请了中国国际金融股份有限公 司（以下简称"中金公司"）担任本次发行的保荐机构。公司与原保荐机构中信建投 证券股份有限公司（以下简称"中信建投"）以及存放募集资金的监管银行签订的《募 集资金专户存储三方监管协议》相应终止，中信建投未完成的持续督导工作由中金公 司承接。 | 招商银行股份有限公司深圳 ...

中国国际金融股份有限公司 关于奥比中光科技集团股份有限公司 首次公开发行部分限售股上市流通的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为 承接奥比中光科技集团股份有限公司（以下简称"奥比中光"、"公司"或"发 行人"）首次公开发行股票并在科创板上市持续督导工作的保荐机构，根据《中 华人民共和国公司法》《中华人民共和国证券法》《证券发行上市保荐业务管理 办法（2023 年修订）》《上海证券交易所科创板股票上市规则（2020 年 12 月修 订）》及《科创板上市公司持续监管办法（试行）》等有关法律法规和规范性文 件的要求，对奥比中光首次公开发行部分限售股解禁上市流通事项进行了审慎核 查，具体核查情况及核查意见如下： 2023 年 7 月 7 日，公司首次公开发行部分限售股及战略配售限售股共计 147,950,530 股限售股上市流通，具体内容详见公司于 2023 年 6 月 30 日在指定 信息披露媒体《上海证券报》《中国证券报》《证券时报》《证券日报》、经济 参考网（www.jjckb.cn）和上海证券交易所网站（www.sse.com.cn）披露的《首次 公开发行部分限售股上市 ...

证券代码：688322 证券简称：奥比中光 公告编号：2023-049 根据中国证券监督管理委员会于 2022 年 4 月 22 日出具的《关于同意奥比中光科 技集团股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕849 号），同 意公司首次公开发行股票的注册申请。公司首次向社会公众公开发行人民币普通股 （A 股）股票 40,001,000 股，并于 2022 年 7 月 7 日在上海证券交易所科创板上市， 发行完成后总股本为 400,001,000 股，其中有限售条件流通股 369,057,256 股，占公司 股本总数的 92.26%，无限售条件流通股 30,943,744 股，占公司股本总数的 7.74%， 具体内容详见公司于 2022 年 7 月 6 日在上海证券交易所网站（www.sse.com.cn）披 露的《奥比中光科技集团股份有限公司首次公开发行股票科创板上市公告书》。 2023 年 1 月 9 日，公司首次公开发行网下配售限售的 1,613,446 股限售股上市流 通，具体内容详见公司于 2022 年 12 月 28 日在指定信息披露媒体《上海证券报》《中 国证券报》《证券时报》 ...

Financial Performance - As of the end of the reporting period, the company's total assets reached CNY 3,427.19 million, a year-on-year increase of 34.17%[16] - The net assets attributable to shareholders of the listed company amounted to CNY 3,231.01 million, reflecting a year-on-year growth of 40.69%[16] - The company achieved operating revenue of CNY 350.05 million, a decrease of 26.17% year-on-year[16] - The net profit attributable to shareholders of the listed company was a loss of CNY 289.78 million, a reduction in loss of 6.9% year-on-year[16] - The company reported a basic earnings per share of -0.77 CNY for 2022, an improvement from -0.86 CNY in 2021[83] - The net profit attributable to the parent company was -289.7829 million yuan, a decrease in loss of 6.90% year-on-year[60] - The net profit attributable to the parent company after deducting non-recurring gains and losses was -338.4916 million yuan, an increase in loss of 12.26% compared to the previous year[60] - The company reported a total comprehensive income of -183,153,165.61 CNY, compared to -160,013,601.82 CNY in the previous year[144] - Total comprehensive income attributable to the parent company was -287,290,337.18 CNY, compared to -240,669,722.71 CNY in the previous year, reflecting a decline[142] - The company reported a net loss of CNY 42,332,652.82 for 2022, compared to a net loss of CNY 62,977,354.57 in 2021, indicating an improvement in financial performance[141] Research and Development - Research and development expenses accounted for 108.73% of operating revenue in 2022, an increase of 27 percentage points compared to 2021[83] - The company has developed a "3D visual perception structure light depth computing engine chip," which won the second prize for technological invention in Shenzhen[113] - The company is committed to ongoing research and development of new products and technologies to enhance market competitiveness[186] - The company has a total of 592 R&D personnel, including 48 PhDs, which represents about 8.1% of the total workforce[95] - Research and development expenses for 2022 were CNY 380,591,553.65, slightly down from CNY 387,519,899.41 in 2021, showing a focus on maintaining R&D investment[140] Market Strategy and Partnerships - The company has formed strategic partnerships in the 3D scanning and modeling field, enhancing user experience and expanding market potential[4] - The company is actively exploring the smart home market through collaborations with door manufacturers, leveraging its 3D visual technology[3] - The company has established partnerships with major cloud platforms like Alibaba Cloud and Tencent Cloud, facilitating mass production and shipment of high-end video doorbell solutions[21] - The company plans to enhance its overseas market presence and brand influence, focusing on detailed analysis of specific projects[111] - The company is focused on internal production methods, aligning production with customer orders and sales forecasts[118] Product Development and Innovation - The company has launched multiple 3D visual perception solutions for various types of robots, leading to rapid growth in shipments[9] - The company has developed a new self-cleaning sweeping robot series, equipped with advanced depth sensing technology for improved navigation and obstacle avoidance[11] - The new U3 product features significant optimizations, achieving facial recognition speed of less than 1 second, height range of 1.2m-2m, and average power consumption of less than 0.68W[20] - The company has launched the I3 identity verification module, which has been widely accepted in the medical insurance verification market, with over 20 provinces in China adopting the technology[22] - The company has achieved mass production of a million-level area array 3D visual sensor, joining a select group of global companies[111] Financial Position and Assets - The total value of trading financial assets increased from approximately ¥359.88 million to ¥573.66 million, with a change of ¥213.78 million during the reporting period[32] - The company’s total assets and liabilities amounted to CNY 3,830,330,964.30 and CNY 3,681,308,595.50 respectively, indicating a solid financial position[140] - The total owner's equity at the beginning of the year was approximately 2.69 billion, with a reduction of approximately 453.55 million in undistributed profits[181] - The company received a total of approximately 106.66 million in owner contributions during the year[181] Operational Insights - The company is currently in a steady growth phase, with expectations for improved profitability as scale and product differentiation advantages become more pronounced[43] - The company is committed to high levels of investment in attracting top talent and core underlying technologies to seize market opportunities during the large-scale commercialization phase[43] - The company emphasizes sustainable development and has integrated this concept into its daily operations, improving employee working conditions[95] - The company operates multiple subsidiaries, including ORBBEC INTERNATIONAL LIMITED and Shenzhen Aoxin Micro Vision Technology Co., Ltd.[185] Challenges and Future Outlook - The company has not yet achieved profitability due to the interdisciplinary nature of its 3D vision perception technology, which involves multiple fields such as optics, mechanics, electronics, chips, and algorithms[43] - The company experienced a decline in operating revenue in 2022 due to significant impacts on downstream customer demand from economic downturns[84] - The company aims to enhance its overall competitiveness by strengthening independent innovation capabilities and deepening core competencies[43] - The company is focused on sustainable layout and strategic reserves for technology, which may lead to faster conversion of R&D results[43]

Financial Performance - The company's operating revenue for Q1 2023 was RMB 61,261,213.90, representing a decrease of 25.83% compared to the same period last year[10]. - The net profit attributable to shareholders of the listed company was a loss of RMB 68,120,785.16, with a net profit excluding non-recurring gains and losses of RMB 83,595,878.20[10]. - The company reported a net loss of $1.38 billion for Q1 2023, compared to a net loss of $1.31 billion in Q1 2022, indicating a worsening of 5.2%[22]. - The net profit attributable to the parent company was -68,120,785.16, compared to -60,909,408.41 in the previous period, indicating a decline of approximately 11.5%[25]. - The total comprehensive income attributable to the parent company was -69,080,859.81, down from -61,060,349.17, reflecting a decrease of about 13.3%[26]. - The operating profit was -70,477,327.09, an improvement from -75,640,126.60 in the previous period, showing a reduction in losses[25]. - The total profit was -70,683,362.98, slightly better than -75,648,859.93 in the previous period, indicating a narrowing of losses[25]. Cash Flow - The net cash flow from operating activities was negative at RMB 92,571,439.75, indicating a significant cash outflow compared to the previous year[10]. - The company experienced a significant decrease in cash received from sales of goods and services compared to the previous year, impacting cash flow from operating activities[13]. - In Q1 2023, the cash inflow from operating activities totaled $95,375,203.16, a decrease of 63.1% compared to $258,511,116.78 in Q1 2022[47]. - The net cash outflow from operating activities was $92,571,439.75, contrasting with a net inflow of $30,443,678.95 in the same period last year[47]. - The total cash outflow from operating activities was $187,946,642.91, down from $228,067,437.83 in Q1 2022, indicating a decrease of 17.6%[47]. - The cash inflow from the sale of goods and services was $69,934,301.53, down from $139,638,883.14 in Q1 2022, a decrease of 49.9%[47]. - The cash received from investment recoveries was $812,804,581.63, significantly up from $353,700,000.00 in Q1 2022, marking an increase of 130%[47]. - The cash received from investment income was $12,793,707.98, compared to $2,868,908.45 in Q1 2022, reflecting a growth of 346%[47]. - The cash inflow from tax refunds was $2,125,065.54, compared to $2,769,144.45 in Q1 2022, a decline of 23.3%[47]. Assets and Liabilities - Total assets at the end of the reporting period were RMB 3,391,311,112.31, down 1.05% from the end of the previous year[11]. - Total assets decreased to $3.39 billion as of March 31, 2023, from $3.43 billion at the end of 2022, a decline of 1.0%[22]. - Equity attributable to shareholders of the listed company was RMB 3,181,441,973.33, reflecting a decrease of 1.53% compared to the previous year[11]. - The total equity attributable to shareholders decreased to $3.18 billion from $3.23 billion, a decline of 1.6%[22]. - The company's total liabilities reached $221.18 million, an increase from $205.25 million in the previous year, marking an increase of 7.8%[22]. - Non-current liabilities increased to $65.03 million in Q1 2023, up from $54.58 million in Q1 2022, reflecting a rise of 19.1%[22]. Research and Development - Research and development expenses totaled RMB 77,573,402.45, which is a decrease of 11.01% year-on-year, but the proportion of R&D expenses to operating revenue increased to 126.63%[10]. - Research and development expenses in Q1 2023 amounted to $77.57 million, compared to $87.17 million in Q1 2022, indicating a decrease of 11%[24]. Other Activities - The company has not disclosed any new product developments or market expansion strategies during this reporting period[10]. - There were no significant mergers or acquisitions reported in the current quarter[10].

证券代码：688322 证券简称：奥比中光 公告编号：2023-027 奥比中光科技集团股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2023 年 5 月 15 日（星期一）下午 16:00-17:00 会议召开地点：上海证券交易所（以下简称"上交所"）上证路演中心 （http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 5 月 8 日（星期一）至 2023 年 5 月 12 日（星期五） 16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@orbbec.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 一、 说明会类型 奥比中光科技集团股份有限公司（以下简称"公司"）已于 2023 年 4 月 29 日在上交所网站（http://www.sse.com.cn）披露了《奥比中光科技集团股份有 限公司 ...

Financial Performance - The company's revenue for Q3 2022 was ¥62,061,482.76, representing a decrease of 58.46% compared to the same period last year[4] - The net profit attributable to shareholders was -¥81,831,102.14, with a year-to-date net profit of -¥205,292,726.65, indicating significant losses[4] - Total revenue for the first three quarters of 2022 was CNY 245,081,553.32, a decrease of 21.2% compared to CNY 310,891,096.12 in the same period of 2021[19] - Operating profit for the first three quarters of 2022 was a loss of CNY 262,101,798.31, compared to a loss of CNY 221,984,925.06 in the same period of 2021[19] - The company reported a net loss of CNY 261,926,679.52 for the first three quarters of 2022, worsening from a loss of CNY 242,223,955.23 in the previous year[19] - The net profit for Q3 2022 was -223,613,149.09 RMB, compared to -209,201,045.25 RMB in Q3 2021, indicating a year-over-year increase in net loss of approximately 6.5%[20] - The total comprehensive loss for Q3 2022 was -219,758,700.22 RMB, slightly higher than -209,452,051.82 RMB in the same period last year[20] Research and Development - Research and development (R&D) expenses totaled ¥97,816,835.12 for the quarter, accounting for 157.61% of revenue, an increase of 92.71 percentage points year-on-year[5] - The company plans to continue focusing on R&D despite the revenue decline, indicating a commitment to innovation and future growth[8] - Research and development expenses for the first three quarters of 2022 were CNY 291,483,615.27, compared to CNY 269,550,420.59 in the same period of 2021[19] Assets and Liabilities - Total assets increased by 35.97% to ¥3,473,120,154.26 compared to the end of the previous year[5] - The equity attributable to shareholders rose by 43.78% to ¥3,301,968,561.82, driven by funds raised from the company's public offering[5] - Non-current assets totaled CNY 746,432,952.87, an increase from CNY 679,175,337.62 year-over-year[17] - Total liabilities decreased to CNY 174,545,913.10 from CNY 248,676,265.67 year-over-year[17] Cash Flow - The net cash flow from operating activities was -¥34,513,390.29 for the year-to-date period, reflecting a decline of 338.20%[4] - Operating cash flow for the first nine months of 2022 was -34,513,390.29 RMB, a significant decline from 14,489,380.09 RMB in the first nine months of 2021[22] - Cash inflow from operating activities totaled 538,450,760.80 RMB, while cash outflow was 572,964,151.09 RMB, resulting in a negative cash flow from operations[22] - Investment activities generated a net cash outflow of -950,062,976.64 RMB, compared to -166,370,263.32 RMB in the previous year[23] - The company received 1,075,700,000.00 RMB from investment recoveries, a substantial increase from 276,000,000.00 RMB in the same period last year[22] Shareholder Information - The company has a total of 8,026 ordinary shares outstanding as of the report date[11] - The largest shareholder, Huang Yuanhao, holds 27.23% of the shares, totaling 108,903,960 shares[11] Market and Product Development - The decline in revenue was primarily due to reduced demand for the company's 3D visual perception products, influenced by the ongoing impact of the pandemic on key industries[7] - The company has not disclosed any significant new product developments or market expansion strategies in the current report[13] - There are no significant mergers or acquisitions reported during the period[13]